# Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy

> **NCT06416397** · — · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 200 (estimated)

## Conditions studied

- Cholangiocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Proteomic profile

## Key facts

- **NCT ID:** NCT06416397
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-08
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06416397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06416397, "Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06416397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*